- •Dedication
- •Preface
- •Acknowledgements
- •Contributors
- •Contents
- •1. Minimally Invasive Oculoplastic Surgery
- •1.1 General Points
- •1.2 Lower Lid Entropion
- •1.2.1 Introduction
- •1.2.2 Lower Lid Entropion Sutures
- •1.2.3 Lower Lid Entropion Botulinum Toxin
- •1.3 Lower Lid Ectropion
- •1.3.1 Introduction
- •1.3.2 The Royce Johnson Suture
- •1.3.3 The Pillar Tarsorrhaphy
- •1.4 Distichiasis
- •1.4.1 Introduction
- •1.4.2 Direct Excision of Lashes
- •1.5 Ptosis
- •1.5.1 Introduction
- •1.5.3 Anterior Approach – One Stitch Aponeurosis Repair
- •1.5.4 Supramid Brow Suspension
- •1.6 Lid Retraction
- •1.6.1 Introduction
- •1.6.2 Koornneef Blepharotomy
- •1.6.3 Botulinum Toxin
- •1.7 Lid Tumours
- •1.7.1 Mohs’ Micrographic Surgery
- •1.7.2 Lamella Sparing Tumour Excision
- •References
- •2. Minimally Invasive Conjunctival Surgery
- •2.1 Conjunctival Surgery
- •2.2 Conjunctivochalasis
- •2.2.1 Background of the Disease
- •2.2.2 Indication for Surgery
- •2.2.3 Basic Concept of Surgery
- •2.2.4 Surgical Procedure
- •2.2.5 Postoperative Follow-Up
- •2.3 Pterygium
- •2.3.1 Background of the Disease and the Concept of Minimally Invasive Surgery
- •2.3.2 Indication for Surgery
- •2.3.3 Basic Concept of Surgery
- •2.3.4 Surgical Procedures
- •2.3.5 A Biologic Adhesive for Sutureless Pterygium Surgery
- •2.3.6 Postoperative Follow-Up
- •2.4 Limbal and Conjuntival Dermoids
- •2.4.1 Background of the Disease
- •2.4.2 Basic Concept of Surgery
- •2.4.3 Surgical Procedure
- •2.4.4 Postoperative Follow-Up
- •2.5 Strabismus Surgery
- •2.6 Conclusion
- •References
- •3. Minimally Invasive Lacrimal Surgery
- •3.1 Introduction
- •3.1.1 Causes of Stenoses of the Lacrimal Drainage System
- •3.1.3 General Remarks Regarding Surgical Management
- •3.2 Endonasal Endoscopic (Microscopic) Dacryocystorhinostomy (EDCR)
- •3.2.1 Indication for EDCR
- •3.2.2 Surgical Technique
- •3.2.3 Silicone Stenting for EDCR
- •3.2.2.1 Silicone “Cones” (Lacrimal Duct Stent, Bess, Berlin)
- •3.2.4 Use of Mitomycin C for EDCR
- •3.2.5 Post-Operative Care After EDCR
- •3.2.6 Results of EDCR
- •3.3 Endonasal Endoscopic Laser Dacryocystorhinostomy (ELDCR)
- •3.3.1 Indications for ELDCR
- •3.3.2 Contraindications for ELDCR
- •3.3.3 Surgical Technique for ELDCR
- •3.3.4 Potential Problems with ELDCR
- •3.3.5 Post-Operative Care After ELDCR
- •3.3.6 Results of ELDCR
- •3.4 Dacryoendoscopy with Transcanalicular Laserdacryoplasty (TLDP)
- •3.4.1 Indication for TLDP
- •3.4.2 Contraindication for TLDP
- •3.4.3 Surgical Technique for TLDP
- •3.4.4 Results of TLDP
- •3.5 Microdrill Dacryoplasty (MDP)
- •3.5.1 Indication for MDP
- •3.5.2 Contraindication for MDP
- •3.5.3 MDP Procedure
- •3.5.4 Results of MDP
- •3.6 Balloon Dilatation
- •3.6.1 Indications for Balloon Dilatation
- •3.6.2 Anaesthesia for Balloon Dilatation
- •3.6.3 Surgical Technique with 2 mm or 3 mm Balloon for Incomplete Stenosis
- •3.6.3.1 Post-Operative Care
- •3.6.3.2 Complications
- •3.6.3.3 Results
- •3.6.4.1 Post-Operative Care
- •3.6.4.2 Results
- •3.6.4.3 Complications
- •3.7 Stent Placement
- •3.7.1 Indications for Stent Placement
- •3.7.3 Surgical Technique for Stent Placement
- •3.7.5 Results of Stent Placement
- •References
- •4. Minimally Invasive Corneal Surgery
- •4.1 Penetrating Keratoplasty
- •4.1.1 Introduction
- •4.1.2 Indications
- •4.1.3 Preoperative Evaluation of the Keratoplasty Patient
- •4.1.4 Preparation for Penetrating Keratoplasty
- •4.1.4.1 Eyelid Speculum
- •4.1.4.2 Scleral Fixation Rings
- •4.1.4.3 Large and Fine-Tipped Needle Holder
- •4.1.4.4 Toothed Forceps
- •4.1.4.5 Trephine Blades
- •4.1.4.6 Radial Marker
- •4.1.4.7 Cornea Punch
- •4.1.4.8 Cutting Block
- •4.1.4.9 Scissors
- •4.1.4.10 Cannulas and Blades
- •4.1.5 Preoperative Medications
- •4.1.6 Penetrating Keratoplasty Surgical Procedure
- •4.1.6.1 Placement of the Scleral Fixation Ring
- •4.1.6.2 Marking of the Host Cornea
- •4.1.6.3 Sizing of the Trephine
- •4.1.6.4 Trephination of the Host Cornea
- •4.1.6.5 Trephination of the Donor Cornea
- •4.1.6.6 Removal of the Host Cornea
- •4.1.6.7 Placement of the Donor Cornea Tissue in the Host Stromal Bed
- •4.1.6.8 Placement of the Cardinal Sutures
- •4.1.6.9 Completion of Suturing
- •4.1.6.10 Suture Techniques
- •4.1.6.11 Subconjunctival Medications
- •4.1.7 Intraoperative Complications
- •4.1.7.1 Scleral Perforation
- •4.1.7.2 Damage to the Donor Button
- •4.1.7.4 Posterior Capsule Rupture
- •4.1.7.5 Vitreous Loss
- •4.1.7.6 Anterior Chamber Hemorrhage
- •4.1.7.7 Choroidal Hemorrhage
- •4.1.8 Postoperative Management
- •4.1.8.1 Postoperative Immunosuppressive Regimen
- •4.1.9 Postoperative Complications
- •4.1.9.1 Wound Leaks
- •4.1.9.2 Epithelial Defects
- •4.1.9.3 Suture-Related Problems
- •4.1.9.4 Increased Intraocular Pressure
- •4.1.9.5 Post-Keratoplasty Astigmatism
- •4.1.10.1 Wedge Resections and Compression Sutures
- •4.1.10.2 Relaxing Incisions
- •4.1.10.3 LASIK
- •4.1.10.4 Photorefractive Keratectomy with Mitomycin C
- •4.1.11 Corneal Allograft Rejection
- •4.1.11.1 Host Risk Factors
- •4.1.11.2 Vascularized Corneas
- •4.1.11.3 Prior Graft Loss
- •4.1.11.4 Graft Diameter
- •4.1.11.5 Anterior Synechiae
- •4.1.11.6 Previous Intraocular Surgery
- •4.1.11.7 Herpes Simplex
- •4.1.12 Treatment of Allograft Rejection
- •4.1.13 Large Diameter Penetrating Keratoplasty
- •4.1.14 Summary
- •References
- •4.2 Descemet’s Stripping Endothelial Keratoplasty
- •4.2.1 Introduction
- •4.2.2 Descemet’s Stripping Endothelial Keratoplasty Surgical Technique
- •4.2.2.1 Donor Cornea Preparation
- •4.2.2.2 Host Cornea Preparation
- •4.2.2.3 Insertion of the Donor Cornea
- •4.2.3 Postoperative Medications
- •4.2.4 Donor Dislocation Risks
- •4.2.5 Repositioning Donor Tissue
- •4.2.6 Treatment of Rejection Episodes
- •4.2.7 Visual and Refractive Outcomes
- •4.2.8 Other Complications
- •4.2.9 Summary
- •References
- •4.3 Pterygium
- •4.3.1 Introduction
- •4.3.2 Treatment of Pterygium
- •4.3.3 Surgical Technique
- •4.3.3.1 Removal of the Pterygium
- •4.3.3.2 Harvesting the Conjunctival Autograft
- •4.3.3.3 Securing the Conjunctival Autograft
- •4.3.3.4 Fibrin Glue vs. Nylon Sutures
- •4.3.4 Postoperative Management
- •4.3.5 Recurrent Pterygium
- •4.3.6 Other Techniques in Pterygium Removal
- •4.3.6.1 Bare Scleral Technique
- •4.3.6.2 Adjunctive Agents
- •Mitomycin C
- •Beta-Irradiation
- •4.3.6.3 Amniotic Membrane Transplantation
- •4.3.7 Complications in Pterygium Removal
- •4.3.8 Summary
- •References
- •5. Minimally Invasive Refractive Surgery
- •5.1 Trends in Refractive Surgery
- •5.2 Introduction
- •5.3 Cornea Refractive Surgery
- •5.3.1 Laser In Situ Keratomileusis (LASIK)
- •5.3.1.1 Advances in Flap Creation Technology
- •Microkeratomes
- •Femtosecond Laser
- •5.3.1.2 Technological Advances in Laser Delivery Platforms
- •5.3.1.3 Faster Excimer Lasers
- •5.3.1.4 Reduction of Collateral Thermal Tissue Damage
- •5.3.1.5 Advanced Eye Trackers
- •5.3.2 PRK and Advanced Surface Ablations (ASA)
- •5.3.2.1 Decrease Thermal Load on the Cornea
- •5.3.2.2 Use of Wound-Healing Modulators
- •5.3.2.3 Trend Towards EPI-LASIK
- •5.3.3 Summary
- •5.4 Intraocular Refractive Surgery
- •5.4.1 Phakic Intraocular Lens Surgery
- •5.4.1.1 Advances in Diagnostic Equipment
- •5.4.1.2 Types of Phakic Intraocular Lens
- •5.4.1.3 Kelman-Duet Phakic Intraocular Lens
- •Lens Design
- •Surgical Technique
- •Pre-Operative Preparation
- •Operative Procedure
- •Post-Operative Care
- •Results
- •Refractive Outcomes
- •Corneal Endothelium
- •5.4.1.4 Visian Implantable Collamer Lens
- •Lens Design
- •Surgical Technique
- •Pre-Operative Preparation
- •Operative Procedure
- •Post-Operative Care
- •5.4.1.5 Results
- •5.4.2 Summary
- •5.5 Lens and Cataract Surgery
- •5.5.2 The Ideal MICS Intraocular Lens
- •5.5.2.1 Aspheric Intraocular Lenses
- •5.5.2.2 Toric Intraocular Lenses
- •5.5.2.3 ACRI.LISA 366D and ACRI.LISA TORIC 466TD
- •Lens Design
- •5.5.2.4 Surgical Technique
- •Operative Procedure
- •Post-Operative Care
- •5.5.2.5 Results
- •5.5.3 Summary
- •5.6 The Future: Beyond the Horizon of Refractive Surgery Today
- •Reference
- •6. Minimally Invasive Strabismus Surgery
- •6.1 Introduction
- •6.2 Nonsurgical Treatment
- •6.4 Rectus Muscle Procedures
- •6.4.1 MISS Rectus Muscle Recession
- •6.4.2 MISS Rectus Muscle Plication
- •6.4.3 Parks’ Rectus Muscle Recession
- •6.4.4 Parks’ Rectus Muscle Plication
- •6.4.5 MISS Rectus Muscle Posterior Fixation Suture
- •6.4.7 MISS Rectus Muscle Repeat Surgery
- •6.4.8 MISS Rectus Muscle Transposition Surgery
- •6.5 Oblique Muscle Procedures
- •6.5.1 MISS Inferior Oblique Muscle Recession
- •6.5.2 MISS Inferior Oblique Muscle Plication
- •6.5.3 MISS Superior Oblique Muscle Recession
- •6.5.4 MISS Superior Oblique Muscle Plication
- •6.5.6 Mühlendyck’s Partial Posterior Superior Oblique Tenectomy for Congenital Brown’s Syndrome
- •6.6 Postoperative Handling
- •6.7.1 Intraoperative Complications
- •6.7.2 Postoperative Complications
- •6.8 Suggestions on How to Start Doing MISS
- •6.8.1 Instruments Suitable for MISS
- •6.8.2 Suture Materials Used for MISS
- •6.8.3 General Remarks Regarding MISS Procedures
- •6.8.4 MISS Dose–Response Relationships
- •References
- •7. Minimally Invasive Iris Surgery
- •7.1 Instrumentation
- •7.2 Sutures
- •7.3 Surgical Principles of Iris Suturing
- •7.3.1 Mobilization
- •7.3.2 Intraocular Suturing and Knot Tying
- •7.3.3 Reattachment of Iris to Sclera
- •7.3.4 Pupil Repair
- •7.3.5 Adjunctive Pupil Repair Techniques
- •References
- •8. Minimally Invasive Glaucoma Surgery
- •Introduction
- •8.1.1 Introduction to Deep Sclerectomy
- •8.1.2 Anesthesia
- •8.1.3 Surgical Technique
- •8.1.3.1 Preparation
- •8.1.3.3 Deep Flap Preparation
- •8.1.3.5 Peeling of Schlemm’s Canal and Juxtacanalicular Meshwork
- •8.1.3.6 Drainage Device
- •8.1.3.7 Wound Closure
- •8.1.4 Postoperative Management and Medication
- •8.1.4.1 Medication
- •8.1.4.2 Management
- •8.1.5 Adjunctive Treatments
- •8.1.5.1 Bleb Needling
- •8.1.5.2 Nd:YAG Goniopuncture
- •8.1.6 Complications and Management
- •8.1.6.1 General
- •8.1.6.2 Perioperative Complications
- •8.1.6.3 Early Postoperative Complications
- •8.1.6.4 Late Postoperative Complications
- •Open-Angle Glaucoma
- •Pigmentary Glaucoma
- •Pseudoexfoliation Glaucoma
- •Aphakic Glaucoma
- •Sturge–Weber Syndrome
- •Glaucoma Secondary to Uveitis
- •Congenital and Juvenile Glaucoma
- •Narrow-Angle Glaucoma
- •Posttrauma Angle-Recession Glaucoma
- •Neovascular Glaucoma
- •Narrow-Angle Glaucoma in a Young Patient
- •Pseudophakic Glaucoma with an A/C IOL
- •8.2.1.4 Preoperative Considerations
- •8.2.2 Anesthesia
- •8.2.4 Postoperative Management and Medication
- •8.2.5 Outcomes and Comparison with Other Techniques
- •8.2.6 Complications and Management
- •8.2.6.1 General
- •8.2.6.4 Summary and Key Points
- •References
- •8.3 New Minimally Invasive, Sclerothalamotomy Ab Interno Surgical Technique
- •8.3.1 Introduction to the Sclerothalamotomy Ab Interno
- •8.3.1.1 Indications for the Sclerothalamotomy Ab Interno
- •8.3.2 Anesthesia
- •8.3.3 Surgical Technique
- •8.3.3.1 Preparation
- •8.3.3.2 Diathermy Probe Insertion
- •8.3.4 Postoperative Management and Medication
- •8.3.5 Outcomes and Comparison with Other Techniques
- •8.3.6 Complications and Management
- •8.3.6.1 General
- •8.3.6.3 Conclusions
- •References
- •Type of Glaucoma
- •Stage of Glaucoma
- •Combined Surgery
- •8.4.2 Anesthesia
- •8.4.3 Surgical Technique
- •8.4.3.1 Preparation
- •8.4.3.2 Implantation of the Micro-Bypass Stent
- •8.4.4 Postoperative Management and Medication
- •8.4.5 Outcomes and Combination with Other Techniques
- •8.4.5.1 Trabecular Implant in Refractory Glaucoma Patients
- •8.4.6 Conclusions
- •References
- •9. Minimally Invasive Cataract Surgery
- •10. Minimally Invasive Vitreoretinal Surgery
- •10.1 Introduction
- •10.2 Microincision Vitrectomy
- •10.2.1 Models of Wound Architecture
- •10.2.2 Vitrectomy
- •10.2.3 Adjuncts
- •10.2.4 Common Surgical Techniques
- •10.2.4.1 Macular Surgery
- •10.2.4.2 Proliferative Diabetic Retinopathy
- •10.2.4.3 Retinal Detachment
- •10.2.4.4 Pediatric Vitreoretinal Surgery
- •10.2.5 Complications
- •10.2.6 Future Developments in Minimally Invasive Vitrectomy
- •10.3 Endoscopic Vitreoretinal Surgery
- •10.3.1 Introduction
- •10.3.2 History and Development of Endoscopic Ophthalmic Surgery
- •10.3.3 The Endoscope
- •10.3.4 Applications of Intraocular Endoscopy
- •10.3.4.1 Media Opacity
- •10.3.4.3 PVR and Subretinal Surgery
- •10.3.4.4 Retained Lens Fragments
- •10.3.4.5 Anterior and Retrolental Vitrectomy in Malignant Glaucoma
- •10.3.4.5 Sutured IOL and ECP
- •10.3.5 Limitations and Challenges
- •10.4 Future Directions of Minimally Invasive Vitreoretinal Surgery
- •References
- •INDEX
3 Minimally Invasive Lacrimal Surgery |
35 |
and location of the ostium, post-operative stenosis of the common canaliculus and endonasal scarring [86].
In the context of minimal invasive procedures, which is the topic of this book, the following alternative operations have to be discussed. They all provide less morbidity for the patient and less operative time:
¥Endonasal endoscopic (microscopic) dacryocystorhinostomy (EDCR)
¥Endonasal endoscopic laser dacryocystorhinostomy (ELDCR)
¥Dacryoendoscopy with transcanalicularl Laserdacyroplasty (TLDP)
¥Dacryoendoscopy with transcanalicular microdrill procedure (MDP)
¥Interventional radiology
¥Balloon dilatation
¥Stenting
Fig. 3.1 Dacryolith: indication for endonasal DCR
3.2Endonasal Endoscopic (Microscopic) Dacryocystorhinostomy (EDCR)
Endonasal dacryocystorhinostomy allows the simultaneous surgical management of endonasal pathologies such as septal deviation, chronic sinusitis, ethmoid cells impinging medially on the lacrimal sac or an enlarged middle turbinate extending too far anteriorly. These anatomical corrections not only treat the pathologies but also facilitate follow-up treatment and should therefore provide better results in the end. Moreover, with the endonasal approach, there is no externally visible scar; division of the medial palpebral ligament and removal of the bony framework for the suspension of the horizontal lacrimal ducts are avoided. In addition, the operating time is shorter and post-opera- tive morbidity is lower than with the external procedure [16].
stage procedure with external incision and later operation is not necessary. It also reduces patient morbidity. Dacryoliths too are good indications for endonasal DCR (Fig. 3.1). Sometimes patients report that symptoms are less severe they lie down for sleeping because the dacryolith moves upwards.
Primary endonasal management of pre-saccal stenoses is also not a problem [28]. Either primary resection of the stenotic pre-saccal portion of the canaliculus is performed endonasally or the stenosis is stented and widened over a period of months by probing and bouginage and insertion of silicone tubing. Recurrences after treatment of intraand post-saccal stenosis can again be treated endonasally. Recurrences of a pre-sac- cal stenosis in which reconstruction of the lacrimal passages cannot reliably be achieved are an indication for conjunctivorhinostomy or for insertion of a HeermannJones tube [83].
3.2.1 Indication for EDCR
Indications include all forms of post-saccal and intrasaccal stenosis. In particular, dacryoliths can be removed in this way. Acute dacryocystitis is also an ideal indication for endonasal procedure as an operation in the acute stage can both evacuate the empyema and treat the underlying post-saccal stenosis [45, 47]. A two-
3.2.2Surgical Technique (See Video Enclosed, See Additionally Training CD-ROM [8, 35, 36, 84], Fig. 3.2a–i)
Surgery is usually performed under general anaesthesia. Procedures under local anaesthesia are feasible
36 |
|
R. K. Weber |
a |
b |
c |
d |
e |
f |
|
||
|
|
g |
h |
i |
|
|
Fig. 3.2 (a–i) Endonasal DCR on the right side (endoscopic view with a 45¡ endoscope). (a) Exposure of the bone over the lacrimal sac (processus frontalis maxillae). (b) Removal of the bone with a drill (microdebrider, 15¡ angle, 5 mm diameter, Karl Storz, Tuttlingen, Germany). (c) Stepwise further removal of bone with parts of the lacrimal sac visible. (d) The lacrimal sac
protrudes spontaneously into the nasal cavity. (e) Probing of the lacrimal sac via the inferior canaliculus. (f) Incision of the lacrimal with a sickleknife. (g) Removal of the mobilised medial wall of the lacrimal sac. (h) Probing demonstrates the position of the common canalis, which is completely free. (i) Irrigation of the lacrimal system proves an open and unobstructed pathway
when general anaesthesia is not recommended or the patient prefers it. In these cases, inÞltration of the supratrochlear and infraorbital nerves is added to the intranasal topical anaesthesia. However, topical anaesthesia of the lacrimal sac may be difÞcult when an acute infection is present. The nasal cavity is vasoconstricted using cottonoids soaked in topical anaesthesia with epinephrine (1:1,000). The agger nasi is inÞltrated with local anaesthesia and epinephrine (1:200,000).
According to the available literature, the manner of visualisation (microscope, endoscope, head lamp) has no inßuence on the outcome [94], but the author favours the endoscopic approach (45¡ or 0¡, 30¡), which is less invasive than the microscopic procedure.
Occasionally, the head of the middle turbinate may need to be trimmed to achieve a proper approach to the lacrimal sac. Septal deviations facing the Agger nasi should be corrected prior to the DCR. If this is the only
3 Minimally Invasive Lacrimal Surgery |
37 |
deviated septal area, a minimised septoplasty through an ÒLÓ-shaped mucosal incision is prefered, followed by circumscribed cartilage resection or correction and reposition of the mucosal ßap. Thus, providing a larger space between the septum and lacrimal sac makes it easier to carry out post-operative care.
Some authors recommend the creation of mucosal ßaps [8, 50, 75, 79]. The ßap measures about 1 cm in height and half a cm in width. At the end of the DCR, the mucosal ßap is repositioned to create an anastamosis between the lacrimal sac mucosa and nasal mucosa, partially covering the lateral wall.
In the case of Agger nasi, two vertical incisions are made through the mucosa down to the bone, slightly anteriorly and superiorly to the middle turbinate, using the Freer elevator, and the mucosa is removed.
The posterior edge of the ascending part of the maxilla is called the Òmaxillary lineÓ. It provides a clear anatomic landmark and the bone resection is performed from this edge anteriorly. The bone may be very strong. The true lacrimal bone, located more laterally and posteriorly, is quite thin and more fragile.
Dissection of the lacrimal sac can be achieved by different methods.
¥Bone removal with the help of hammer and chisel, the latter directed towards the orbit, implies a strong conÞdence in the person holding the hammer. Backbiting of the process with Kerrison rongeurs, postioned at the very edge of the Òmaxillary lineÓ is feasible as long as the bone is not too thick.
¥In these cases it is better to employ a diamond or cutting burr under irrigation with saline to drill the ascending process of the maxilla, until a circumscribed exposure of the lacrimal sac surface is achieved.
¥Alternatively microdebrider burrs with a 15¡ bent head are very helpful, particularly in endoscopic DCR.
If there is any doubt about the correct identiÞcation of the lacrimal sac, the surgeon can introduce a lacrimal probe through the inferior canaliculus or press against the sac from outside and then push gently. The lacrimal sac may be identiÞed by its bulge (Fig. 3.2). Then, a 90¡ Kerrison rongeur is used to remove additional bone anteriorly and a 45¡ Kerrison rongeur to remove the bone superiorly until the entire medial wall and most of the anterior wall of the lacrimal sac are exposed in its superior aspect, where the common canaliculus enters the sac.
8,8+/-0,2 mm
4,1+/-2,3 mm
Fig. 3.3 Topographic anatomy of the lacrimal sac using the middle turbinate as landmark (data from 76 CT [96])
A large part of the lacrimal sac lies above the attachment of the middle turbinate and above the oriÞce of the common canaliculus (Fig. 3.3). Endonasally, adequate exposure is shown by spontaneous tenting of the lacrimal sac into the nasal cavity.
While a helping hand exercises a Þrm pressure from outside (best: putting a Þnger on the inner edge of the eye) a vertical incision is then made in the anterior face of the lacrimal sac with the help of a number 11 or a sickle knife. The pressure from outside prevents the sack from the lateral displacement when trying to make the incision. The entire medial wall is removed using straight Blakesley forceps or true cutting forceps. In cases of severe inßammation or infection the medial wall is easily removed by sheer force with the instrument. At this point, pus or mucus usually ßows from the sac.
The likelihood of a successful outcome is very high if at the end of the operation practically the entire medial wall of the lacrimal sac has been removed and its lateral wall can heal with the adjacent nasal and paranasal sinus mucosa unhindered by neighbouring structures.
¥The bony window must be sufÞciently large to allow for shrinking, which is sometimes considerable. For this, the bone should be removed as far as the fornix, i.e. depending on the anatomy, beyond the medial palpebral ligament (in a rostral direction).
¥If there is any doubt, the opening of the anterior ethmoid cells or resection of the uncinate process should be performed generously so as to minimise any potential for obstruction dorsally.
